CRM vs PG: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Salesforce, Inc. · Technology
$182.14
+200.4% upside to fair value
Grade B High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$143.45
+13.8% upside to fair value
Grade B High Quality
QuantHub Verdict
CRM has more upside to fair value (+200.4%). PG trades at a lower forward P/E (20.8x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric CRM PG
Current Price $182.14 $143.45
Fair Value Estimate $547.17 $163.27
Upside to Fair Value +200.4% +13.8%
Market Cap $173.0B $334.0B
Forward P/E 22.8x 20.8x
EV / EBITDA 14.4x 15.4x
Price / Sales 4.2x 3.9x
Price / FCF 12.0x 22.2x
Revenue Growth YoY +12.1% +7.4%
Gross Margin 77.7% 50.3%
Operating Margin 21.5% 23.2%
Return on Equity 12.4% 31.3%
Dividend Yield 0% 0%
FCF Yield 8.33% 4.5%
Analyst Consensus Buy Buy
Investment Thesis
CRM — Salesforce, Inc.
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
PG — The Procter & Gamble Company
The Procter & Gamble Company is a leading consumer defensive firm specializing in household and personal products with a diversified portfolio across fabric and home care, baby and family care, beauty, health care, and grooming segments. The business quality is high, supported by durable brands, strong margins with a 50.3% gross margin and 19.2% net margin, and consistent earnings growth evidence…
Accumulation Zones
Metric CRM PG
Zone Low $410.38 $122.45
Zone High $465.09 $138.78
In Buy Zone? Yes No
← CRM Research    PG Research →    All Research